Cargando…
Improved Survival of Lymphoma Patients with COVID-19 in the Modern Treatment and Vaccination Era
SIMPLE SUMMARY: Patients with lymphoma are at greater risk of complications from COVID-19 infection. However, limited data exists on COVID-19-related outcomes in lymphoma patients since the use of COVID-19 vaccines and treatments began. Our study reports the real-world outcomes of 68 lymphoma or CLL...
Autores principales: | Della Pia, Alexandra, Zhao, Charles, Jandir, Parul, Gupta, Amolika, Batistick, Mark, Kim, Gee Youn (Geeny), Xia, Yi, Ahn, Jaeil, Magarelli, Gabriella, Lukasik, Brittany, Leslie, Lori A., Goy, Andre H., Ip, Andrew, Feldman, Tatyana A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454633/ https://www.ncbi.nlm.nih.gov/pubmed/36077782 http://dx.doi.org/10.3390/cancers14174252 |
Ejemplares similares
-
Anti-spike antibody response to the COVID vaccine in lymphoma patients
por: Della Pia, Alexandra, et al.
Publicado: (2022) -
COVID-19 Impact on Lymphoma Patients' Clinical Outcomes - an Observational Cohort Study
por: Ip, Andrew, et al.
Publicado: (2020) -
Phase 1b Dose-finding Study of Venetoclax With Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
por: Petrillo, Alessandra, et al.
Publicado: (2022) -
Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid Neoplasms
por: Ip, Andrew, et al.
Publicado: (2022) -
Urological reconstruction in the modern era
por: Thorpe, Andrew C.
Publicado: (2013)